CME Group Inc Class A
CME: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|Ml | LOCK|Sw | LOCK|@%c%gT>h |
CME Earnings: Normalization in Market Activity Leads to More-Modest Results
CME reported decent third-quarter results as trading activity normalized from recent highs. Revenue fell 3% from last year and 9% from last quarter to $1.54 billion. Meanwhile, earnings per share fell to $2.49 from $2.51 as higher expenses were offset by strong nonoperating income.
